Gastro Flashcards

1
Q

Which LFTs suggest hepatocellular injury?

A

ALT/AST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are causes of hepatocullular injury ?

A

Hepatitis (viral, alcoholic, ischaemic)
Liver cirrhosis
Drug / toxin-induced liver injury (e.g. paracetamol overdose)
Malignancy (hepatocellular carcinoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what in the ALT/AST suggest alcoholic liver disease

A

The AST:ALT ratio can help determine the aetiology of hepatocellular injury, with a >2:1 ratio classical of alcoholic liver disease.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

where is ALP released from?

A

Serum alkaline phosphatase (ALP) is derived from biliary epithelial cells (cells lining the biliary tract) and bones.3 Raised ALP levels can therefore be caused by cholestasis or bone disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where is GGT released from?

A

Gamma-glutamyltransferase (GGT) is found in hepatocytes and also biliary epithelial cells.2 It is a non-specific but highly sensitive marker of liver damage and cholestasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ALP with normal GGT

A

An ALP rise with normal GGT suggests bone disease (e.g. Paget’s disease, vitamin D deficiency, bony metastases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ALP with a rise GGT rise?

A

An ALP rise with associated GGT rise is more suggestive of cholestasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Isolated GGT

A

An isolated GGT rise is classically associated with alcohol excess.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bilirubin metabolism

A

When red blood cells are broken down, unconjugated (insoluble) bilirubin is created as a waste product and binds to albumin in the bloodstream
Hepatocytes take up unconjugated bilirubin and metabolise it to form conjugated (soluble) bilirubin
Hepatocytes excrete conjugated bilirubin into the biliary tract, where it flows into the bowel lumen as bile
Gut bacteria further metabolise bilirubin in bile to form urobilinogen, which is eventually excreted in the stools as stercobilinogen
A small amount of urobilinogen is reabsorbed from the intestine into the portal venous system, and as urobilinogen is water-soluble, the kidney is able to excrete some of this into the urine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pre-hepatic jaundice?

A

Pre-hepatic jaundice occurs when increased red blood cell breakdown produces excess bilirubin. This can overwhelm metabolism/excretion pathways, leading to jaundice.

The most common cause of increased red blood cell breakdown is haemolysis. Bilirubin is unconjugated in the blood, as the hepatocytes have not yet metabolised it. The remainder of LFTs are generally normal, as the liver is otherwise working well.

Hint: In pre-hepatic jaundice, patients are often anaemic due to excess red blood cell breakdown. The diagnosis may be Gilbert’s syndrome if no anaemia is present.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Gilbert’s syndrome?

A

Gilbert’s syndrome is a congenital disorder present in up to 5% of the population. It results from a deficiency of glucosyltransferase, the enzyme responsible for the conjugation of bilirubin within hepatocytes.

Gilbert’s syndrome classically presents following viral infection with raised bilirubin but normal LFTs/ full blood count. The disease is benign and requires no specific management.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hepatocellular jaundice

A

Hepatocellular jaundice occurs when hepatocytes are damaged and dysfunctional, leading to an inability to metabolise unconjugated bilirubin from the bloodstream. This leads to high levels of unconjugated bilirubin in the blood. There will generally also be very high ALT / AST levels, marking hepatocyte damage.

Hint: Common causes of hepatocellular injury are covered above (hepatitis, cirrhosis, malignancy, drug or toxin insult). When liver injury is severe, there are not enough functioning hepatocytes to metabolise bilirubin, and jaundice will develop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cholestatic jaundice

A

Cholestasis is an interruption in bile flow from hepatocytes to the gut. When this interruption is severe, bilirubin levels will build up in the blood. The bilirubin has been metabolised in the liver, and thus the bilirubin in the blood is predominantly conjugated bilirubin. There will generally also be high ALP levels with associated high GGT, marking dysfunction of the biliary system.

Obstructive jaundice will classically lead to dark urine and pale stools. Bilirubin cannot enter the gastrointestinal tract due to cholestasis, leading to low stercobilinogen excretion in stools.

The bilirubin in the blood is conjugated and can be filtered by the kidneys. The presence of conjugated bilirubin gives the urine a very dark colour.

Hint: Stools may also be pale in hepatocellular jaundice, as there is decreased bilirubin metabolism/excretion, however as the bilirubin in the blood is unconjugated, it will not be able to pass into the urine. Therefore, the urine should remain a normal colour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

causes of cholestasis??

A

Causes of intrahepatic obstruction (obstruction of the hepatic bile canaliculi):

Hepatitis
Cirrhosis
Malignancy
Drugs (e.g. antibiotics, oral contraceptive pills, anabolic steroids)
Pregnancy
Causes of extrahepatic obstruction (obstruction of hepatic ducts, or distal biliary tree):

Gallstones
Primary sclerosing cholangitis
Intraluminal malignancy: cholangiocarcinoma
Extraluminal malignancy causing duct compression: head of pancreas tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

comparing the pattern of ALT and ALP res

A

A greater than 10-fold increase in ALT and a less than 3-fold increase in ALP suggests a predominantly hepatocellular injury
A less than 10-fold increase in ALT and a more than 3-fold increase in ALP suggests cholestasis
It is possible to have a mixed picture involving both hepatocellular injury and cholestasis
An isolated ALP rise without a GGT rise should raise your suspicion of bony pathology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Liver Screen

A

Hepatitis serology (A/B/C)
Epstein-Barr Virus (EBV)
Cytomegalovirus (CMV)
Anti-mitochondrial antibody (AMA)
Anti-smooth muscle antibody (ASMA)
Anti-liver/kidney microsomal antibodies (Anti-LKM)
Anti-nuclear antibody (ANA)
p-ANCA
Immunoglobulins – IgM/IgG
Alpha-1 Antitrypsin (to rule out alpha-1 antitrypsin deficiency)
Serum Copper (to rule out Wilson’s disease)
Ceruloplasmin (to rule out Wilson’s disease)
Ferritin (to rule out haemochromatosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

causes of acute liver failure?

A

paracetamol overdose
alcohol
viral hepatitis (usually A or B)
acute fatty liver of pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clinical features of acute liver failure?

A

Features*
jaundice
coagulopathy: raised prothrombin time
hypoalbuminaemia
hepatic encephalopathy
renal failure is common (‘hepatorenal syndrome’)

*remember that ‘liver function tests’ do not always accurately reflect the synthetic function of the liver. This is best assessed by looking at the prothrombin time and albumin level.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the definition of acute liver failure?

A

Acute liver failure (ALF) is a rare, life-threatening, potentially reversible condition with a rapid decline in hepatic function characterised by jaundice, coagulopathy (INR >1.5), and hepatic encephalopathy in patients with no evidence of prior liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How is liver failure classified?

A

ALF may be classified as hyperacute, acute, or subacute, depending on the interval from the onset of jaundice to the development of encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When should acute liver failure be discussed with transplant centre?

A

All cases of acute liver failure should be discussed with a transplant centre for consideration of transfer; however, robust supportive management prior to transfer is crucial.
For any acute liver injury with significant or worsening (liver-related) coagulopathy, rapid recognition and evaluation of severity should be followed by prompt discussion with a liver transplant centre, facilitating early provision of advice and transfer where appropriate.
.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is acute liver injury?

A

Acute liver injury (ALI) is defined as an acute derangement in liver function tests associated with liver-related coagulopathy, in the absence of underlying chronic liver disease (CLD)1. A subset progress to acute liver failure (ALF), a relatively rare syndrome characterised by altered consciousness due to hepatic encephalopathy (HE) in the setting of an ALI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is acute on chronic liver failure?

A

cute-on-chronic liver failure (ACLF) is a distinct phenomenon, involving rapidly progressive organ failure in the context of established cirrhosis, triggered by superimposed liver injury or extrahepatic precipitants such as infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How is acute liver failure subcategorised?

A

ALF can be subcategorised by time elapsed between onset of jaundice and development of encephalopathy, into “hyperacute” (< 7 days), “acute” (7-28 days), and “subacute” (4-24 weeks) liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Assessment and initial investigations for acute liver failure?

A

Stabilise the patient through robust supportive care
Determine aetiology
Acquire baseline investigations and establish severity
Exclude CLD and causes of secondary liver dysfunction (e.g. ischaemic hepatitis/malignant hepatic infiltration1)
Ensure timely liaison with an LT centre.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Specific questions in history in a patient with acute liver failure?

A

Presentation - time from onset of jaundice to encephalopathy
last time patient was clinically well

PMH
co-morbidities, previous abdominal surgery, performance status, exercise tolerance

Drug history - paracetamol, over the counter, herbal remedies, recent abx

SH - travel, smoking alcohol, drugs, high risk sexual behaviour

mental health

FH - Wilsons disease, IHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Investigations for ALF?

A

Bloods
FBC, U&E’s
LFT including split bilirubin
Coagulation screen
group and save
Ammonia

ABG

Non invasive liver screen - Viral, autoanibody screen, metabolic

Paracetamol level

Septic screen

CT head, chest, abdominal, pelvis with triple phase liver imaging to assess vasculature

Echo
ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Management of acute liver failure

A

ALF patients are usually intravascularly deplete, so hypotension mandates aggressive initial fluid resuscitation; where response is inadequate, inotropes (including Noradrenaline and Vasopressin) are utilised to maintain adequate mean arterial pressure (MAP)1.

Endotracheal intubation to ensure airway protection is indicated in Grade 3-4 HE. Patients risk raised intracranial pressure from cerebral oedema driven by hyperammonaemia11. Neuroprotection is mandated (including nursing at 30º, Sodium control targeting 145-150mmol/L, high-volume CVVHF to lower ammonia levels, and avoidance of hypercapnia)

ALF patients are vulnerable to bacterial and fungal infections, which can preclude LT or increase post-LT mortality11. Prophylactic broad spectrum antibiotics and anti-fungals are indicated.

Prothrombin time/INR is a key marker of hepatic function, informing prognosis and guiding the need for LT3. Parenteral Vitamin K (10mg) should be administered, but coagulopathy should not be corrected without clear rationale (i.e. if bleeding)1,3, or following discussion with the LT centre.

Hepatological: N-acetylcysteine is indicated for all ALF patients, irrespective of aetiology1,3,12.

Enteral feeding with laxatives and enemea

Monitor for AKI

Patients are at risk of hypoglycaemia, and blood glucose should be checked hourly. Phosphate may fall rapidly, requiring aggressive replacement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Decompensated Cirrhosis care bundle?

A

Investigations
Bloods, blood cultures, USS abdomen

Ascitic tap irrespective of clotting parameters and send to lab

If high alcohol intake - prescribe pabrinex and commence treatment for alcohol withdrawal if needed.

Treat with abx

SBP with abx and HAS

Manage AKI and hyponatramia
Suspend diuretics and nephrotoxic drugs
Fluid resuscitation - HAS or NaCL
Fluid balance
Map > 80

Esceleta to higher care

Manage GI bleeding
Fluid resuscitation
IV terlipressin
Prophylactic abx
PT prolonged - give IV VK, If > 20 seconds give FFP
If pets < 50 give IV pets
Transfer if Hb < 70

Lactulose 20-30mg TDS and phosphate enema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How to differentiate ascites ?

A

SAAG can differentiate ascites resulting from portal hypertension and from other causes. It is more useful than the protein based exudate / transudate concept. Calculate SAAG by:

SAAG = (serum albumin) – (ascites albumin)

If SAAG >11g/L then ascites very likely the result of portal hypertension (97% accuracy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what would lead to SAAG < 11g/L

A

diffuse peritoneal mets
TB peritonitis
pancreatic ascites
Nephrotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what would cause a SAAG > 11g/L

A

Cirrhosis
alcohol hepatitis
Cardiac ascites
massive liver mets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what should VTE prophylaxis be held in liver disease?

A

when Platelet count is < 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Differential diagnosis for abdominal pain?

A

Peptic ulcer
appendicits
pancreatitis
Biliary colic
acute cholecystitis
diverticulitis
AAA
Intestinal obstruction

Unusual causes :
acute coronary syndrome
diabetic ketoacidosis
pneumonia
acute intermittent porphyria
lead poisoning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Clinial features of acute upper GI bleeding?

A

Haematemesis
Melena
rise in urea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Differentials for UGIB?

A

oesophageal varicose
Oesophagitis
Cancer
Mallory weiss tear
Gastric ulcer
Diffuse erosive gastritis
Dieulafor lesion (arteriovenous malformation)
Aortic enteric fistula

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

risk assessments in upper GI bleed?

A

the Glasgow-Blatchford score at first assessment
helps clinicians decide whether patients can be managed as outpatients or not

the Rockall score is used after endoscopy
provides a percentage risk of rebleeding and mortality
includes age, features of shock, co-morbidities, aetiology of bleeding and endoscopic stigmata of recent haemorrhage

38
Q

What is the the Glasgow blatchford score?

A

Urea
Hb
BP

HR
Hepatic disease
Cardiac failure
syncope
Melena

39
Q

how is UGIB managed?

A

Resuscitation - ABCDE, Wide bore IV access x 2
Platelet transfusion if pets < 50
FFP to patients who have either a fibrinogen level of less than 1 g/litre, or a prothrombin time (international normalised ratio) or activated partial thromboplastin time greater than 1.5 times normal
prothrombin complex concentrate to patients who are taking warfarin and actively bleeding

Endoscopy - immediately after resuscitation in patients with severe bleed, should be within 24 hours for all patients

PPI if non-variceal bleeding

If suspected variceal bleed then do not give PPI

Variceal bleeding - terlipressing and prophylactic antibiotics
Band ligations
TIPS transjugular intrahepatic portosystemic shunts

40
Q

causes of pancreatitis?

A

Gallstones
Ethanol
Trauma
Steroids
Mumps (other viruses include Coxsackie B)
Autoimmune (e.g. polyarteritis nodosa), Ascaris infection
Scorpion venom
Hypertriglyceridaemia, Hyperchylomicronaemia, Hypercalcaemia, Hypothermia
ERCP
Drugs (azathioprine, mesalazine*, didanosine, bendroflumethiazide, furosemide, pentamidine, steroids, sodium valproate)

41
Q

clinical features of pancreatitis?

A
  • abdominal pain
  • N&V
  • Jaundice
  • shock
  • tachypnoea
  • temp may be low or normal initially but may develop persistent fever as the inflammatory responses progress
  • abdo tenderness with local guarding
  • Grey turners (flanks) and Cullen’s signs (peri-umbilical)

ARDS

42
Q

Investigations of pancreatitis?

A

amylase
serum lipase (higher sensitivity and specificity)

CT abdomen

43
Q

what can lead to an increase in amylase?

A

Upper gastrointestinal perforation
Mesenteric or bowel ischaemia
Renal failure
Retroperitoneal haematoma
Intra-abdominal ectopic pregnancy
Inflammation or obstruction of the salivary glands

44
Q

management of pancreatitis?

A

Analgesia
Anti-emetics
NG tube on free drainage if vomiting is.a problem
Nutrition as early as possible
Fluid resuscitation (patients may need 10L of fluid in the first 24 hours)
Monitor BMs

45
Q

complications of acute pancreatitis?

A

Peripanceatic fluid collection
Pancreatic absces

pancreatic necrosis
Pseudocyst formation
Ascites
Retroperitoneal haemorrhage

46
Q

causes of C.diff?

A

C. difficile diarrhoea is primarily caused by the disruption of gut microbiota secondary to antibiotic use.
Broad-spectrum antibiotics can lead to the depletion of protective bacteria, creating an environment conducive to C. difficile overgrowth.
The most commonly implicated antibotics are:
Cephalosporins
Clindamycin
Co-amoxiclav

Risks
- advanced age
- prolonged hospitalisation
- Immunosupression
- recent GI surgery

47
Q

Clinical features of C.diff?

A

diarrhoea
abdominal pain
a raised white blood cell count is characteristic
if severe toxic megacolon may develop

48
Q

Investigations for C.diff?

A

is made by detecting Clostridium difficile toxin (CDT) in the stool
Clostridium difficile antigen positivity only shows exposure to the bacteria, rather than current infection

49
Q

Management of C.diff?

A

first-line therapy is oral vancomycin for 10 days
second-line therapy: oral fidaxomicin
third-line therapy: oral vancomycin +/- IV metronidazole

50
Q

Infectious causes of Diarrhoea?

A

Bacterial infections: Common organisms include Escherichia coli, Campylobacter jejuni, Salmonella and Shigella. These often present with acute onset diarrhoea, abdominal pain, fever and sometimes bloody stools.
Viral infections: Notably Rotavirus, Norovirus, and Cytomegalovirus (CMV). Typically characterised by sudden onset watery diarrhoea, vomiting and low-grade fever.
Parasitic infections: Such as Giardia lamblia, Cryptosporidium, and Entamoeba histolytica. These may cause chronic or intermittent diarrhoea with associated weight loss and malabsorption symptoms.

51
Q

Non-infectious causes of Diarrhoea?

A

-Infectious Causes
Gastrointestinal disorders: Including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), coeliac disease, lactose intolerance. These conditions often present with chronic or recurrent diarrhoea. Associated symptoms like abdominal pain, bloating, weight loss or blood in stool can provide clues to the specific disorder.
Malignancies: Colorectal cancer or lymphoma may present with changes in bowel habits including diarrhoea. There may be associated rectal bleeding, anaemia or unexplained weight loss.
Medication induced: Numerous medications like antibiotics, laxatives, antacids containing magnesium can cause diarrhoea. The onset is usually related to the start of medication.

52
Q

Systemic disorders causing diarrhoea?

A

Endocrine disorders: Hyperthyroidism and Addison’s disease can present with diarrhoea due to increased gut motility and malabsorption respectively.
Liver and pancreatic diseases: Conditions like chronic pancreatitis or liver cirrhosis can lead to malabsorption causing fatty diarrhoea (steatorrhoea).

53
Q

Aetiology of UC?

A

Genetic susceptibility
Immune dysregulation
Environmental factors
Gut microbiota

54
Q

Classification of ulcerative colitis?

A

Ulcerative proctitis: Inflammation is limited to the rectum.
Proctosigmoiditis: Involves the rectum and sigmoid colon.
Left-sided colitis: Extends from the rectum to the splenic flexure.
Pancolitis: Affects the entire colon.

55
Q

Clinical features of UC?

A

Diarrhoea
Bloods stools
Mucus in stools
Abdominal pain
Tenesmus (a constant urge to defecare despite an empty colon can cause significant distress)

Fever, fatigue, anorexia and weight loss s

56
Q

Extra-intestinal features of UC?

A

Arthralgia
Uveitis
Erythema nodosum
Primary closing cholangitis

57
Q

Investigations for ulcerative colitis?

A

FBC, CRP and ESR
Faecal calprotectin
Sigmoidoscopy with colonoscopy

MRI or CT

58
Q

Findings on colonoscopy and biopsy in patients with ulcerative colitis?

A

red, raw mucosa, bleeds easily

no inflammation beyond submucosa (unless fulminant disease)

widespread ulceration with preservation of adjacent mucosa which has the appearance of polyps (‘pseudopolyps’)

inflammatory cell infiltrate in lamina propria

neutrophils migrate through the walls of glands to form crypt abscesses

depletion of goblet cells and mucin from gland epithelium
granulomas are infrequent

Crypt Atrophy and Paneth Cell Metaplasia

59
Q

difference between UC and Crohn’s on histology?

A

Crohns
Inflammation in all layers from mucosa to serosa
increased goblet cells
granulomas

UC
No inflammation beyond submucosa (unless fulminant disease) - inflammatory cell infiltrate in lamina propria
neutrophils migrate through the walls of glands to form crypt abscesses
depletion of goblet cells and mucin from gland epithelium
granulomas are infrequent

60
Q

Differences between UC and Crohn’s on Radiology?

A

Crohns
Small bowel enema
high sensitivity and specificity for examination of the terminal ileum
strictures: ‘Kantor’s string sign’
proximal bowel dilation
‘rose thorn’ ulcers
fistulae

UC:
Barium enema
loss of haustrations
superficial ulceration, ‘pseudopolyps’
long standing disease: colon is narrow and short -‘drainpipe colon’

61
Q

Management of UC?

A

Aminosalicylates (mesalamine, sulfasalazine) are used first line

Corticosteroids - prednisolone, hydrocortisone, budesonide

Immunomodulators - Azathiorpine, 6-mercaptopurine, methotrexate

Biologic therapies: Anti-tumor necrosis factor (anti-TNF) agents (infliximab, adalimumab, golimumab), anti-integrin agents (vedolizumab), and anti-interleukin-12/23 agents (ustekinumab) are used for patients with moderate-to-severe UC who are refractory to conventional treatments.

Janus kinase (JAK) inhibitors: Tofacitinib is an oral JAK inhibitor approved for the treatment of moderate-to-severe UC in patients who do not respond to or are intolerant of other treatments.

Surgery

62
Q

how is the severity of UC classified?

A

mild: < 4 stools/day, only a small amount of blood
moderate: 4-6 stools/day, varying amounts of blood, no systemic upset
severe: >6 bloody stools per day + features of systemic upset (pyrexia, tachycardia, anaemia, raised inflammatory markers)

63
Q

How to induce remission in UC?

A

Mild-moderate
Proctitis
- topical aminosalicylate (rectal mesalazine). If remission not achieved within 4 weeks and an oral aminiosalicylate, if remission still not achieved - oral or topical steroids

proctosigmoiditis and left-sided ulcerative colitis
topical (rectal) aminosalicylate
if remission is not achieved within 4 weeks, add a high-dose oral aminosalicylate OR switch to a high-dose oral aminosalicylate and a topical corticosteroid
if remission still not achieved stop topical treatments and offer an oral aminosalicylate and an oral corticosteroid

xtensive disease
topical (rectal) aminosalicylate and a high-dose oral aminosalicylate:
if remission is not achieved within 4 weeks, stop topical treatments and offer a high-dose oral aminosalicylate and an oral corticosteroid

64
Q

How is severe UC managed?

A

should be treated in hospital
intravenous steroids are usually given first-line
intravenous ciclosporin may be used if steroid are contraindicated
if after 72 hours there has been no improvement, consider adding intravenous ciclosporin to intravenous corticosteroids or consider surgery

65
Q

Maintaining remission in UC?

A

Following a mild-to-moderate ulcerative colitis flare
proctitis and proctosigmoiditis
topical (rectal) aminosalicylate alone (daily or intermittent) or
an oral aminosalicylate plus a topical (rectal) aminosalicylate (daily or intermittent) or
an oral aminosalicylate by itself: this may not be effective as the other two options
left-sided and extensive ulcerative colitis
low maintenance dose of an oral aminosalicylate

Following a severe relapse or >=2 exacerbations in the past year
oral azathioprine or oral mercaptopurine

66
Q

what levels should be checked prior to starting Azathioprine?

A

TPMT - thiopurine methytransferase

Azathioprine is generally considered safe to use in pregnancy.

67
Q

complications of UC?

A

Bowel Ca

68
Q

clinical features of Crohn’s disease?

A

Abdominal pain
Diarrhoea
Weight loss
Perianal disease
oral manifestations
obstructive symptoms

Extraintestinal manifestations
Arthritis
Skin manifestations
Uveitis
Primary sclerosing cholangitis
Anaemia

69
Q

Investigations for Crohn’s disease?

A

Colonoscopy (indings may include aphthous ulcers, cobblestoning, and skip lesions.)

Capsule endoscopy

Upper GI endoscopy

70
Q

Differentials for Crohn’s disease?

A

UC

IBS

Intestinal TB - similar symptoms to Crohn’s disease including abdominal pain, weight loss and diarrhoea. However, patients may also exhibit systemic signs such as fever and night sweats which are less common in Crohn’s disease.
Radiologically, intestinal tuberculosis tends to cause ileocaecal involvement mimicking that of Crohn’s disease. However, the presence of necrotic lymph nodes and asymmetric involvement of the intestine may suggest a diagnosis of intestinal tuberculosis over Crohn’s disease.

71
Q

Management of Crohn’s disease?

A

Inducing remission
- Glucocorticoids
- enteral feeding with an elemental diet
- 5 ASA drugs
- Azathioprine or mercaptourine (used as add ons but not as mono therapy)
- Infliximab is useful in refactor disease and fistulating Crohn’s
- metronidazole is often used for isolated peri-anal disease

Maintaining remission
- azathioprine or mercaptopurine is used first-line to maintain remission
- methotrexate is second line

Surgery

72
Q

Complications of Crohn’s ?

A

Strictures
Fistulas
Abscesses
Perianal disease
Malabsorption and nutritional deficiencies
Colorectal cancer

73
Q

causes of viral gastroenteritis?

A

commonly - norovirus
less common - adenovirus

74
Q

Clinical features of viral gastroenteritis?

A

Acute diarrhoea (duration of less than 7 days)

Watery and non-bloody
The presence of blood in the stool should raise suspicion of an alternative diagnosis, such as Shiga-toxin producing E-coli or Campylobacter infection.

Vomiting

Mild fever

Abdominal pain

75
Q

causes of bacterial gastroenteritis?

A

The most common causative bacteria in the UK is Campylobacter jejuni, but other pathogens frequently associated include Salmonella species, E-coli and Shigella.
Campylobacter typically contaminates undercooked meat (especially poultry), unpasteurised milk and untreated water.
E-coli is usually harmless, but it is important to be aware that E-coli O157:H7 infection can progress to haemolytic uraemia syndrome. Typically E-coli is acquired from undercooked beef products (such as beef burgers) and can be transmitted from person to person by direct contact.

76
Q

bacteria causing food poisoning?

A

Staphylococcus aureus: from undercooked meats and cream products.

Bacillus cereus: from reheated rice.

77
Q

differentials for viral gastroenteritis?

A

bacterial gastroenteritis
food poisoning
C.diff
IBD
IBS
Coeliac disease

78
Q

when should a patient with viral gastroenteritis be admitted to hospital?

A

If they are unable to to maintain oral intake due to vomiting
Some elderly individuals >60 years old, who are more at risk of severe dehydration
Abdominal tenderness
Diarrhoea lasting 10 days or more

79
Q

Campylobacter infection symptoms?

A

Diarrhoea - may be blood and may have mucus
abdominal pain
N&V

Fever
muscle aches

80
Q

complications of campylobacter infection?

A

Bacteremia: This is rare but more likely in immunocompromised patients or those with underlying conditions such as liver disease or malignancy.
Pancreatitis, cholecystitis, or appendicitis-like syndrome: These can occur when the infection spreads beyond the gastrointestinal tract.
Post-infectious complications: These include reactive arthritis, Guillain-Barré syndrome, and irritable bowel syndrome. The risk of these complications is low but they can result in significant morbidity.

GBS
Miller Fisher syndrome
Milker’s nodule

81
Q

Management of campylobacter?

A

usually self-limiting
the BNF advises treatment if severe or the patient is immunocompromised. Clinical Knowledge summaries also recommend antibiotics if severe symptoms (high fever, bloody diarrhoea, or more than eight stools per day) or symptoms have last more than one week
the first-line antibiotic is clarithromycin
ciprofloxacin is an alternative although the BNF states that ‘Strains with decreased sensitivity to ciprofloxacin isolated frequently’

82
Q

Symptoms of HUS?

A

The symptoms of HUS can include bloody diarrhoea, abdominal pain, vomiting, and decreased urine output

82
Q

what is Haemolytic Uraemia syndrome?

A

Haemolytic uraemic syndrome (HUS) is a rare but serious condition that can lead to renal failure, anaemia and thrombocytopenia. It is most commonly caused by an infection with certain strains of E. coli bacteria, particularly in children under the age of five. HUS can also be caused by other infections, medications, or genetic factors.

83
Q

Treatment of HUS

A

Treatment for HUS involves supportive care, such as fluid and electrolyte management, blood transfusions, and dialysis if necessary. Antibiotics are not recommended unless there is evidence of an active bacterial infection.

84
Q

genetic pre-disposition to Coeliac disease?

A

HLA-DQ2 or HLA-DQ8

85
Q

Clinical features of Coeliac ?

A

diarrhoea, abdominal pain, and malabsorption to extraintestinal manifestations such as dermatitis herpetiformis, fatigue, anaemia, and neurological complications.

Coeliac disease is associated with an increased risk of complications, including malignancies, osteoporosis, and other autoimmune disord

86
Q

Investigations for coeliac disease?

A

Anti-tissue transglutaminase
(False negative results may occur in patients with selective IgA deficiency)

Anti-endomysial antibodies (EMA)

Total serum IgA levels

Duodenal Biopsy (Villous atrophy, crypt hyperplasia, increased intraepithelial lymphocytes)

87
Q

Differentials for coeliac?

A

IBS

IBD

Non-coeliac gluten sensitivity (NCGS) - unlike coeliac disease, there is no damage to the small intestine in NCGS.
NCGS does not have the same genetic associations as coeliac disease. HLA-DQ2 and HLA-DQ8 are present in nearly all patients with coeliac disease but are not commonly found in those with NCGS.

88
Q

complications of coeliac disease?

A

Malabsorption
Lactose intolerance
Refectory coeliac disease (symptoms despite strict adherence to gluten free diet)

Malignancies - Enteropathy associated T cell lymphoma
Small bowel adenocarcinoma

Osteoporosis and osteopenia

Dermatitis herpetiformis

Infertility and adverse pregnancy outcomes

89
Q

what are the different classifications of peritonitis?

A

Primary Peritonitis - (AKA SBP, typically occurs when there is no identifiable source of infection within the abdomen. It is often associated with conditions leading to ascites such as cirrhosis or nephrotic syndrome.)

Secondary peritonitis - a result of contamination from an intra-abdominal source. Common causes include perforation of a gastrointestinal organ, postoperative complications, trauma or ischemia.

Tertiary peritonitis - refers to persistent or recurrent infection after adequate treatment for primary or secondary peritonitis. It is often seen in immunocompromised patients and those in intensive care units.

90
Q

Features of peritonitis ?

A

Abdo pain
GI symptoms (N&V, bowel disturbance)
Systemic symptoms - fever, tachycardia, hypotension

Abdominal distension

Peritoneal signs - tenderness, guarding, rigidity, indicative of peritoneal inflammation, percussion tenderness may also be present